Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
abiraterone (zytiga) (1 trial)
bevacizumab (avastin) (4 trials)
cytarabine (cytosar-u) (1 trial)
decitabine (dacogen) (1 trial)
fluorouracil (efudex) (5 trials)
irinotecan (Camptosar) (5 trials)
leucovorin (5 trials)
levoleucovorin (fusilev) (4 trials)
onvansertib (9 trials)
oxaliplatin (eloxatin) (1 trial)
paclitaxel (taxol) (1 trial)
prednisone (meticorten) (1 trial)
Colorectal Neoplasms (Phase 2)
Leukemia (Phase 2)
Leukemia, Myeloid (Phase 2)
Leukemia, Myeloid, Acute (Phase 2)
Prostatic Neoplasms (Phase 2)
Trials (9 total)
Trial APIs (12 total)